EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancer

Shouhua Li, Hengtong Han, Kaili Yang, Xiaoxiao Li, Libin Ma, Ze Yang, Yong-Xun Zhao

International Immunopharmacology · 2025-01 · 144 · 113702

DOI: 10.1016/j.intimp.2024.113702 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025-01. Verfasst von Shouhua Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China. Electronic address: lishh2023@lzu.edu.cn. Hauptthemen laut MEDLINE: Tumor Microenvironment, Thyroid Neoplasms, Immunotherapy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The metabolic reprogramming of cancer cells is a hallmark of many malignancies. To meet the energy acquisition needs of tumor cells for rapid proliferation, tumor cells reprogram their nutrient metabolism, which is caused by the abnormal expression of transcription factors and signaling molecules related to energy metabolic pathways as well as the upregulation and downregulation of abnormal metabolic enzymes, receptors, and mediators. Thyroid cancer (TC) is the most common endocrine tumor, and immunotherapy has become the mainstream choice for clinical benefit after the failure of surgical, endocrine, and radioiodine therapies. TC change the tumor microenvironment (TME) through nutrient competition and metabolites, causing metabolic reprogramming of immune cells, profoundly changing immune cell function, and promoting immune evasion of tumor cells. A deeper understanding of how metabolic reprogramming alters the TME and controls immune cell fate and function will help improve the effectiveness of TC immunotherapy and patient outcomes. This paper aims to elucidate the metabolic communication that occurs between immune cells around TC and discusses how metabolic reprogramming in TC affects the immune microenvironment and the effectiveness of anti-cancer immunotherapy. Finally, targeting key metabolic checkpoints during metabolic reprogramming, combined with immunotherapy, is a promising strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentThyroid NeoplasmsImmunotherapyHumansAnimalsCellular ReprogrammingMetabolic Reprogramming

Stichwörter der Autor:innen

Immune microenvironmentImmunometabolismImmunotherapyMetabolic reprogrammingThyroid cancers

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China. Electronic address: lishh2023@lzu.edu.cn.
  • The Seventh Department of General Surgery, Department of Thyroid Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, China. Electronic address: hanht20@126.com.
  • The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China. Electronic address: yangkl2023@lzu.edu.cn.
  • The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China. Electronic address: lxiaoxiao2023@lzu.edu.cn.
  • The Seventh Department of General Surgery, Department of Thyroid Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, China. Electronic address: 455817277@qq.com.
  • The Seventh Department of General Surgery, Department of Thyroid Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, China. Electronic address: doccrazy11@163.com.

Förderung

  • Natural Science Foundation of Gansu Province

Zitieren

APA

Li, S., Han, H., Yang, K., Li, X., Ma, L., Yang, Z., & Zhao, Y. X. (2025). Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancer. International Immunopharmacology, 144, 113702. https://doi.org/10.1016/j.intimp.2024.113702

Vancouver

Li S, Han H, Yang K, Li X, Ma L, Yang Z, et al. Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancer. International Immunopharmacology. 2025;144:113702. doi:10.1016/j.intimp.2024.113702

BibTeX
@article{Li2025,
  author = {Li, Shouhua and Han, Hengtong and Yang, Kaili and Li, Xiaoxiao and Ma, Libin and Yang, Ze and Zhao, Yong-Xun},
  title = {Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancer},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {144},
  pages = {113702},
  doi = {10.1016/j.intimp.2024.113702}
}
Kostenlos starten →